濮阳东方医院割包皮手术费用价格(濮阳东方妇科好么) (今日更新中)

BEIJING, March 14 (Xinhuanet) – "Angry Birds" game developers at Rovio have announced a funding of 42 million U.S. dollars to expand their "mean pigs, cranky birds" empire, according to foreign media report Sunday.The funding, announced Thursday, is the first venture-capital money Rovio has secured. Richard Wong with Accel Partners, who led the firm's investment in Rovio, hailed "Angry Birds" as "an incredible consumer franchise beyond just being a mobile game."With the newly raised funding, "Angry Birds" developers have made a strategic plan to achieve the brand growth of "Angry Birds."According to developer Peter "Mighty Eagle" Vesterbacka, Rovio is going to expand the franchise of "Angry Birds" in a lot of directions such as movie, broadcast and TV."We are working on a game that will involve Facebook ... really the plan is to make "Angry Birds" playable everywhere," said Vesterbacka. Besides its efforts in digital realm, Rivio is also exploring the potential toy market. Ravio has already sold over two million "Angry Birds" plush toys, which have broken into the mainstream retail channels. Recently Ravio has also branched out into selling "Angry Bird" apparel."Angry Birds", hatched in 2009, has dominated Apple's list of top-selling iPhone apps since it took flight last year. It is now available on many other platforms -- iPad, Android, iTouch, and almost every other smartphone out there.The game became world-polupar as it is easy to pick up and very addictive. Rovio, a mobile game development studio founded in Finland in 2003, enjoys the reputation as one of the most innovative game shops in Europe.

WASHINGTON, March 22 (Xinhua) -- A long-term study by Greek researchers has shown the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cells in treating people with aggressive forms of multiple sclerosis (MS).The study was published on Tuesday in Neurology, the medical journal of the American Academy of Neurology.For the treatment, chemotherapy drugs are used to kill all of the patient's blood cells, including the immune cells that are believed to be attacking the body's own central nervous system. Bone marrow stem cells removed from the patient are purified and transplanted back into the body, which saves life by replacing the blood cells and also is proposed to "reboot" the immune system.A human embryonic stem cell line derived at Stanford University is seen in this handout photo released to Reuters by the California Institute for Regenerative Medicine, March 9, 2009The study followed 35 people for an average of 11 years after transplant. The study involved people with rapidly progressive MS who had tried a number of other treatments for MS with little or no effect. All were severely disabled by the disease, with an average score of six on a scale of disease activity that ranges from zero being a normal neurological examination to 10 meaning death due to MS.A score of six means able to walk with a cane or crutch; a seven is mainly in a wheelchair. All had worsened by at least one point on the scale in the year prior to the transplant.After the transplants, the probability of participants having no worsening of their disease for 15 years was 25 percent. The probability was higher -- 44 percent -- for those who had active brain lesions, which are a sign of disease activity, at the time of the transplant.For 16 people, symptoms improved by an average of one point on the scale after the transplant, and the improvements lasted for an average of two years. The participants also had a reduction in the number and size of lesions in their brains. Two people (six percent) died from complications related to the transplant at two months and 2-1/2 years post-transplant.Study author Vasilios Kimiskidis, of Aristotle University in Thessaloniki, Greece, noted that more research is needed on this treatment, including studies that compare people receiving the treatment to a control group that does not receive the treatment."Keeping that in mind, our feeling is that stem cell transplants may benefit people with rapidly progressive MS," he said. "This is not a therapy for the general population of people with MS but should be reserved for aggressive cases that are still in the inflammatory phase of the disease."

SHANGHAI, May, 13 (Xinhua) -- Scientists attending a recent high-level conference on robotics agreed that great progress has been made in the field, but strict rules for the safe usage of robots should be implemented."Four years ago, if you went into a Chinese factory and said 'robots can help you work,' you would be kicked out. But now, China has a large industrial robot market, along with Japan, the Republic of Korea and the United States," says Li Zexiang, general chair of the 2011 International Conference on Robotics and Automation (ICRA 2011), which concluded Friday in Shanghai.Chinese robotics researchers have suggested to the government that rules and regulations for robot usage should be created. Professor Wang Tianmiao from the Beihang University (BUAA) told Xinhua about the suggestions during the conference.Wang says that in the future, it might not be possible for artificial intelligence to take the place of humans in some social roles. However, Wang says that mankind should pay close attention to the possible dangers of advancements in robotics, as the industry is currently undergoing dramatic changes.The five-day conference, which is organized by the Institute of Electrical and Electronics Engineers (IEEE), took place in China for the first time ever since its first session in 1984, which took place in the city of Atlanta in the United States.Media reports show that Japan, the Republic of Korea (ROK) and several Western countries have already drafted rules about the safe use of robots.

JAKARTA, April 27 (Xinhua) -- Marine scientists will begin conducting an ecological survey in eight locations throughout the resort island in Indonesia's Bali province that could be developed as marine managed areas due to their biodiversity and coral structure, the Jakarta Post quoted an expert as saying on Wednesday.The survey, which will take place from April 29 to May 11, will be carried out by four international scientists and local scientists from universities.Ketut Sarjana Putra, the marine program director with Conservation International Indonesia, said Tuesday the survey was aimed at identifying marine species and their population in each of the eight locations.Selected from 25 potential marine conservation zones, the eight locations are Pulaki and Pemuteran, Lovina, Les Village, Tulamben and Amed, Padangbai, Nusa Penida, Bukit Uluwatu Peninsula and Perancak Beach. "We will go around Bali, starting from Sanur in the south, heading east, then covering the northern and the western areas, then back to the south," Ketut told the daily.The survey is part of a process to build a network of marine protected areas to effectively manage the island's marine and coastal resources to sustain environmental and socioeconomic value and benefits, with priority given to the eight locations.

来源：资阳报